SCHEMBL20897979

SCHEMBL20897979

NC(=O)c1cc(F)c(CC2CCN(C(=O)O)CC2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 5/20 0.43
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ TNKS O95271 1/20 0.39
▸ PARP1 P09874 1/20 0.39
▸ PARP14 Q460N5 1/20 0.39
▸ F2 P00734 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28292785 0.82 BTK (0.41) BTKCYP2C9CYP2C19MAPK14GAA
SCHEMBL20971823 0.81 GPR119 (0.52) —
SCHEMBL20897951 0.80 L3MBTL1 (0.45) CA12CA1CA2CA7CA9
SCHEMBL21722888 0.80 CYP2C9 (0.42) BTKCYP2C9CYP2C19MAPK14
SCHEMBL20897972 0.79 MGLL (0.45) BTKCYP2C9CYP2C19MAPK14
SCHEMBL1816284 0.77 PARP10 (0.36) BTKCYP2C9GAAPARP1
SCHEMBL4768629 0.77 GAA (0.67) GAACA12CA1CA2CA7
SCHEMBL5320493 0.76 GAA (0.49) CYP2C9CYP2C19MAPK14GAAF2
SCHEMBL4252210 0.75 HTR2A (0.47) MAPK14GAAF2
SCHEMBL23365144 0.75 CYP2C9 (0.55) CYP2C9CYP2C19MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019072978-A1 MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS Basilea Pharmaceutica International AG (CH) 2019-04-18 — — WO disclosed
Send feedback